Medidata hit by $4.8m wire fraud, but says customer clinical trial data is safe
Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access customer data says the clinical trial IT firm.
Archives for September 28, 2014
Horizon buys Sage for $48m as BIg Pharma turns to personalised medicines for increased return on investment
Merck KGaA’s acquisition of Sigma-Aldrich is testament to Big Pharma’s growing interest in personalized medicine says Horizon Discovery, which has bought Sage Labs for $48m (€38m).
FDA says no to anti-addiction rule on Ritalin, painkillers
The US Food and Drug Administration has rejected a petition to force drugmakers to reformulate CNS-acting drugs like Adderall, Ritalin, and painkillers to prevent illegal use, but experts say the rule is only a matter of time.
PPD increases stake in small molecule discovery company X-Chem citing Big Pharma relationships
CRO PPD has exercised its option to acquire the remaining minority ownership interest of X-Chem for an undisclosed sum. X-Chem will continue to operate as a small molecule discovery company with its entire existing staff and management team.
LabCorp to acquire NMR-focused, personalized diagnostic company LipoScience for $85m
CRO LabCorp has entered a definitive agreement to acquire LipoScience for $5.25 per share, or about $85.3m (€67.2m).
India accuses American Enterprise Institute researchers of "smear campaign"
The Indian Government has accused the authors of a paper analysing the quality of drugs sold in Africa of leading an attack on the Indian drug industry, but researcher Roger Bate says they are “shooting the messenger.”